{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=vecuronium", "query": { "intervention": "vecuronium" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=vecuronium&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T12:01:50.500Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03909165", "title": "Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neuromuscular Blockade" ], "interventions": [ { "name": "Sugammadex 2 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 4 mg/kg", "type": "DRUG" }, { "name": "Neostigmine + Glycopyrrolate", "type": "DRUG" }, { "name": "Neostigmine + Atropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "2 Years", "sex": "ALL", "summary": "1 Day to 2 Years" }, "enrollment_count": 145, "start_date": "2019-07-23", "completion_date": "2023-09-21", "has_results": true, "last_update_posted_date": "2025-07-25", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 7, "location_summary": "Palo Alto, California • Miami, Florida • Oklahoma City, Oklahoma + 4 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03909165" }, { "nct_id": "NCT03263117", "title": "SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Sedation", "type": "DRUG" }, { "name": "General Anesthesia (GA)", "type": "DRUG" }, { "name": "Intra-arterial Thrombectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 260, "start_date": "2018-07-01", "completion_date": "2023-04-22", "has_results": true, "last_update_posted_date": "2025-11-26", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 11, "location_summary": "Indianapolis, Indiana • Iowa City, Iowa • Louisville, Kentucky + 6 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Rochester", "state": "New York" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03263117" }, { "nct_id": "NCT05246397", "title": "Sugammadex Titration in Cardiac Surgery Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Valvular Heart Disease", "Aorta Disease", "Heart Failure" ], "interventions": [ { "name": "Sugammadex administration", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2022-02-01", "completion_date": "2022-11-10", "has_results": true, "last_update_posted_date": "2024-03-21", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05246397" }, { "nct_id": "NCT04545424", "title": "Trial of Therapeutic Hypothermia in Patients With ARDS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Distress Syndrome, Adult" ], "interventions": [ { "name": "Hypothermia", "type": "DEVICE" }, { "name": "Neuromuscular Blocking Agents", "type": "DRUG" }, { "name": "Standard of care", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 340, "start_date": "2021-06-29", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 19, "location_summary": "Los Angeles, California • New Haven, Connecticut • Atlanta, Georgia + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04545424" }, { "nct_id": "NCT03376854", "title": "Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Distress Syndrome, Adult", "Sars-CoV2" ], "interventions": [ { "name": "Hypothermia", "type": "DEVICE" }, { "name": "Neuromuscular Blocking Agents", "type": "DRUG" }, { "name": "Standard of Care", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2018-05-01", "completion_date": "2021-04-27", "has_results": false, "last_update_posted_date": "2021-04-30", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03376854" }, { "nct_id": "NCT03346057", "title": "Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Reversal of Neuromuscular Blockade" ], "interventions": [ { "name": "Sugammadex 2 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 4 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 16 mg/kg", "type": "DRUG" }, { "name": "Neostigmine + Glycopyrrolate", "type": "DRUG" }, { "name": "Rocuronium", "type": "DRUG" }, { "name": "Vecuronium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2017-12-20", "completion_date": "2019-09-04", "has_results": true, "last_update_posted_date": "2020-10-08", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Loma Linda, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03346057" }, { "nct_id": "NCT03219294", "title": "Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arthropathy of Hip" ], "interventions": [ { "name": "Vecuronium 0.1 mg/kg", "type": "DRUG" }, { "name": "Vecuronium 0.2mg/kg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Craig Curry", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 116, "start_date": "2017-05-01", "completion_date": "2018-05-01", "has_results": true, "last_update_posted_date": "2019-09-18", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Portland, Maine", "locations": [ { "city": "Portland", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT03219294" }, { "nct_id": "NCT03540030", "title": "Opioid-Free Shoulder Arthroplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Opioid Use", "Shoulder Osteoarthritis", "Avascular Necrosis", "Rotator Cuff Tear", "Arthritis;Inflammatory" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "toradol", "type": "DRUG" }, { "name": "acetaminophen", "type": "DRUG" }, { "name": "regional block", "type": "DRUG" }, { "name": "propofol", "type": "DRUG" }, { "name": "IV lidocaine", "type": "DRUG" }, { "name": "rocuronium", "type": "DRUG" }, { "name": "vecuronium", "type": "DRUG" }, { "name": "sevoflurane", "type": "DRUG" }, { "name": "desflurane", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OrthoCarolina Research Institute, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 86, "start_date": "2016-09", "completion_date": "2019-06", "has_results": true, "last_update_posted_date": "2020-10-14", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03540030" }, { "nct_id": "NCT02190903", "title": "A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Complications", "Hip Fracture", "Delirium" ], "interventions": [ { "name": "General endotracheal anesthesia", "type": "OTHER" }, { "name": "Regional (spinal) Anesthesia", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2013-10", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2018-07-30", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02190903" }, { "nct_id": "NCT02237443", "title": "Mask Ventilation Before and After Neuromuscular Blockade", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia" ], "interventions": [ { "name": "Rocuronium", "type": "DRUG" }, { "name": "Vecuronium Bromide", "type": "DRUG" }, { "name": "Succinylcholine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 210, "start_date": "2014-08", "completion_date": "2015-02", "has_results": false, "last_update_posted_date": "2015-04-09", "last_synced_at": "2026-09-11T12:01:50.500Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02237443" } ] }